EE+ POEM Archive
Sotrovimab reduces the likelihood of hospitalization in at-risk outpatients with mild to moderate COVID-19 (NNT = 16)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Sotrovimab Reduces the Likelihood of Hospitalization in At-risk Outpatients With Mild to Moderate COVID-19 (NNT = 16)." EE+ POEM Archive, John Wiley & Sons, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315545/all/Sotrovimab_reduces_the_likelihood_of_hospitalization_in_at_risk_outpatients_with_mild_to_moderate_COVID_19__NNT_=_16_.
Sotrovimab reduces the likelihood of hospitalization in at-risk outpatients with mild to moderate COVID-19 (NNT = 16). In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2024. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315545/all/Sotrovimab_reduces_the_likelihood_of_hospitalization_in_at_risk_outpatients_with_mild_to_moderate_COVID_19__NNT_=_16_. Accessed December 11, 2024.
Sotrovimab reduces the likelihood of hospitalization in at-risk outpatients with mild to moderate COVID-19 (NNT = 16). (2024). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315545/all/Sotrovimab_reduces_the_likelihood_of_hospitalization_in_at_risk_outpatients_with_mild_to_moderate_COVID_19__NNT_=_16_
Sotrovimab Reduces the Likelihood of Hospitalization in At-risk Outpatients With Mild to Moderate COVID-19 (NNT = 16) [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2024. [cited 2024 December 11]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315545/all/Sotrovimab_reduces_the_likelihood_of_hospitalization_in_at_risk_outpatients_with_mild_to_moderate_COVID_19__NNT_=_16_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Sotrovimab reduces the likelihood of hospitalization in at-risk outpatients with mild to moderate COVID-19 (NNT = 16)
ID - 1315545
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315545/all/Sotrovimab_reduces_the_likelihood_of_hospitalization_in_at_risk_outpatients_with_mild_to_moderate_COVID_19__NNT_=_16_
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
